Novavax's COVID-19 jab is more than 90 percent effective, the vaccine-maker said. (File)Washington:
Novavax's COVID-19 jab is more than 90 percent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
The jab "demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall," the company said in a statement, adding "the study enrolled 29,960 participants across 119 sites in the U.S. and Mexico to evaluate efficacy, safety and immunogenicity."
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)